Arrowhead Pharmaceuticals (ARWR) Q4 2024 Earnings

Nov 26Confirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-1.38
-1.08
-0.77
-0.47

Details

Expected EPS
-1.120425
Actual EPS
-1.36
Surprise EPS
-0.24
Surprise Percent
-21.38%

Description

⁨Arrowhead Pharmaceuticals⁩ (⁦ARWR⁩) has reported earnings of ⁦-1.36⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts